MedPath

Effectivity of Neurofeedback in youth with AD(H)D-problems and comorbid disorders: a randomized controlled trial

Completed
Conditions
ADHD
Attention Deficit Hyperactivity Disorder
10009841
Registration Number
NL-OMON33860
Lead Sponsor
GGZ Eindhoven (Eindhoven)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
150
Inclusion Criteria

* A positive screen on the Screeningslist ADHD or DSM IV diagnosis ADHD
* IQ > 80

Exclusion Criteria

* IQ < 80
* suffer or have suffered from a medical condition that causes attention problem or hyperactivity (for example: anaemia, organic brain damage, low blodd sugar levels)
* instable EEG pattern, determined with QEEG assessment

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>The effectivity of neurofeedback is investigated with different study<br /><br>parameters. We expect that the brain after neurofeedback will be better<br /><br>capable to proces information than before the neurofeedback; this will be<br /><br>indicated using Event Related Potentials which are determined during the QEEG.<br /><br>Also we expect that the sustained and selective attention and concentration<br /><br>will increase and the executive functions improve. To indicates these changes<br /><br>(neuro)psychological tests will be assessed. Whenever the fundamental problems<br /><br>of AD(H)D-problems are effectively treated we expect that the related behavior<br /><br>problems decrease. Therefore behavioral changes will be investigated using<br /><br>behavioral questionnaires and an interview.</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>xxx</p><br>
© Copyright 2025. All Rights Reserved by MedPath